• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于黑色素瘤的前哨淋巴结阳性,是否需要进行 III 级解剖?

Is a level III dissection necessary for a positive sentinel lymph node in melanoma?

机构信息

Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan, USA.

出版信息

J Surg Oncol. 2012 Mar;105(3):225-8. doi: 10.1002/jso.22076. Epub 2011 Aug 22.

DOI:10.1002/jso.22076
PMID:21882199
Abstract

BACKGROUND

For melanoma patients with a positive axillary SLN, the extent of ALND remains controversial, with debate over whether a level III dissection is needed.

METHODS

We queried our IRB approved prospective database for patients with a positive axillary SLN who had a level I/II dissection only, and compared recurrence and complication rates to the existing literature.

RESULTS

Between 1998 and 2008, 270 patients had 285 level I/II ALNDs for a positive SLN. Median number of SLN removed was 2, while the median number of involved SLN was 1 (range 1-4). An average of 18.7 nodes/ALND were removed, with 13% having positive non-SLN. Post-operative complications occurred in 31 patients (11%), primarily cellulitis (8%). After a mean follow-up of 44 months, 14 patients had a regional recurrence in the axillary basin (5%).

CONCLUSIONS

The complication rate and regional recurrence rate for patients undergoing a level I/II ALND for a positive SLN are either lower than or on par with reported series of ALND for level I, II, and III dissections, suggesting that in this setting, the level III dissection may be of minimal benefit.

摘要

背景

对于前哨淋巴结阳性的黑色素瘤患者,腋窝淋巴结清扫术(ALND)的范围仍存在争议,是否需要进行 III 水平的清扫术存在争议。

方法

我们查询了经过机构审查委员会批准的前瞻性数据库,以确定仅进行了 I/II 水平 ALND 且前哨淋巴结阳性的患者,并将复发率和并发症发生率与现有文献进行了比较。

结果

1998 年至 2008 年间,270 例患者共进行了 285 例 I/II 水平 ALND 以治疗前哨淋巴结阳性。切除的 SLN 中位数为 2 个,而受累 SLN 的中位数为 1 个(范围为 1-4 个)。平均每例 ALND 切除 18.7 个淋巴结,13%的非 SLN 有阳性。31 例(11%)患者发生术后并发症,主要为蜂窝织炎(8%)。平均随访 44 个月后,14 例患者在前哨淋巴结阳性的腋窝区域出现局部复发(5%)。

结论

对于前哨淋巴结阳性的黑色素瘤患者,接受 I/II 水平 ALND 的患者的并发症发生率和局部复发率与 I、II 和 III 水平 ALND 的报道系列相似或更低,这表明在这种情况下,III 水平的清扫术可能益处有限。

相似文献

1
Is a level III dissection necessary for a positive sentinel lymph node in melanoma?对于黑色素瘤的前哨淋巴结阳性,是否需要进行 III 级解剖?
J Surg Oncol. 2012 Mar;105(3):225-8. doi: 10.1002/jso.22076. Epub 2011 Aug 22.
2
The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.前哨淋巴结肿瘤负荷对乳腺癌非前哨淋巴结状态及复发率的影响。
Ann Surg Oncol. 2005 Sep;12(9):705-11. doi: 10.1245/ASO.2005.08.020. Epub 2005 Aug 4.
3
Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.对于前哨淋巴结有微转移的乳腺癌患者,区域控制无需完成腋窝淋巴结清扫。
Arch Surg. 2010 Jun;145(6):564-9. doi: 10.1001/archsurg.2010.84.
4
A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.一项关于乳腺癌前哨淋巴结活检与腋窝淋巴结清扫术的随机临床试验:Sentinella/GIVOM试验结果
Ann Surg. 2008 Feb;247(2):207-13. doi: 10.1097/SLA.0b013e31812e6a73.
5
Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.前哨淋巴结活检时代黑色素瘤的腹股沟淋巴结清扫术。
Surgery. 2007 Jun;141(6):728-35. doi: 10.1016/j.surg.2006.12.018.
6
Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.皮肤黑色素瘤患者前哨淋巴结活检结果为假阴性的生存分析及临床病理因素
Ann Surg Oncol. 2006 Dec;13(12):1655-63. doi: 10.1245/s10434-006-9066-0. Epub 2006 Oct 3.
7
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.与I级和II级腋窝淋巴结清扫术相比,前哨淋巴结活检与淋巴结阴性乳腺癌患者生存率的提高相关。
Eur J Surg Oncol. 2009 Aug;35(8):805-13. doi: 10.1016/j.ejso.2008.09.006. Epub 2008 Nov 28.
8
Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy.前哨淋巴结冰冻切片分析及肿块切除切缘状态对接受保乳治疗患者再次手术率的影响。
J Am Coll Surg. 2008 Jan;206(1):76-82. doi: 10.1016/j.jamcollsurg.2007.07.021. Epub 2007 Oct 18.
9
Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence.再次前哨淋巴结活检:同侧乳腺肿瘤复发管理的新前沿。
Ann Surg Oncol. 2007 Aug;14(8):2209-14. doi: 10.1245/s10434-006-9237-z. Epub 2007 Feb 1.
10
Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.与即刻腋窝淋巴结清扫术(ALND)相比,接受延迟腋窝淋巴结清扫术的前哨淋巴结转移乳腺癌患者的发病率。
Ann Surg Oncol. 2008 Jan;15(1):262-7. doi: 10.1245/s10434-007-9593-3. Epub 2007 Sep 19.

引用本文的文献

1
Current surgical management for melanoma.黑色素瘤的当前外科治疗方法。
J Dermatol. 2024 Mar;51(3):312-323. doi: 10.1111/1346-8138.17086. Epub 2023 Dec 27.
2
Suction Drain Volume following Axillary Lymph Node Dissection for Melanoma-When to Remove Drains? A Retrospective Cohort Study.黑色素瘤腋窝淋巴结清扫术后的引流液量——何时拔除引流管?一项回顾性队列研究。
J Pers Med. 2022 Nov 7;12(11):1862. doi: 10.3390/jpm12111862.
3
Recent Evolution in the Management of Lymph Node Metastases in Melanoma.黑色素瘤淋巴结转移管理的最新进展
Kans J Med. 2021 Mar 19;14(1):64-72. doi: 10.17161/kjm.vol1414674. eCollection 2021.
4
Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan.黑色素瘤前哨淋巴结阳性患者中 II 级和 III 级腋窝淋巴结转移的频率:日本多机构研究。
Int J Clin Oncol. 2016 Aug;21(4):796-800. doi: 10.1007/s10147-015-0944-y. Epub 2016 Jan 13.
5
Dominant lymph drainage in the upper extremity and upper trunk region: evaluation of lymph drainage in patients with skin melanomas.上肢和上胸部区域的优势淋巴引流:皮肤黑色素瘤患者的淋巴引流评估。
Int J Clin Oncol. 2014 Feb;19(1):193-7. doi: 10.1007/s10147-012-0504-7. Epub 2012 Dec 8.